RNA interference is a new approach to knockdown gene expression, but e¡ectiveness varies depending on the organism, cell type or target sequence. Studies with Caenorhabditis elegans have shown that subsets of cells including neurons are often resistant to RNA interference.We measured RNA interference using green £uores-cent protein reporter strains and feeding, soaking and injection delivery methods in a number of Caenorhabditis elegans neuron subtypes (dopaminergic, GABAergic, cholinergic, glutamatergic, touch). The sensitivity to RNA interference varied: GABAergic and dopaminergic neurons showed greater resistance while cholinergic, glutamatergic and touch neurons were more sensitive. Dysfunctional RRF-3, a putative RNA-directed RNA polymerase, had a signi¢cant e¡ect on increasing neuron sensitivity in most subtypes. These results demonstrate that Caenorhabditis elegans neurons vary in their sensitivity to RNA interference. NeuroReport 16:1995^1999
Introduction
RNA interference (RNAi) is a valuable new tool to decrease or knockdown gene expression in eukaryotic organisms and has shown therapeutic potential for a number of diseases [1, 2] . RNAi was first discovered in plants and termed 'cosuppression' [3, 4] and was later defined as RNA interference triggered by double-stranded RNA (dsRNA) [5] . In Caenorhabditis elegans, dsRNA spreads systemically through worm tissues and the effect can persist into the next generation [5] . C. elegans cells often show robust sensitivity to RNAi with the exception of some cell types, most notably neurons [6, 7] .
In C. elegans, dsRNA is digested into a B21-nucleotide small interfering RNA species that is additionally amplified by member/s of the RNA-directed RNA polymerase family [8] . This family contains different members that have both positive and negative influences on the small interfering RNA amplification process [9, 10] . RNA-dependent RNA polymerase family-1 (RRF-1) amplifies new dsRNAs using small interfering RNAs as a primer and mRNA as a template. Another member of the RNA-directed RNA polymerase family, RRF-3, shows an opposite response by inhibiting RNAi effectiveness in C. elegans [11] . As a result of the ability of rrf-3 mutations in C. elegans to decrease the resistance to RNAi in non-neuronal cells, we were interested in determining how different types of neurons in RRF-3-deficient worm strains would respond to RNAi. We hypothesized that specific neurons or neuron types could exhibit a stable level of interference, and we tested this using different delivery methods that could reveal the variance of RNAi effectiveness between different types of neuronal cells. Neurons were typed by the neurotransmitter they used according to standard nomenclature, and were marked by transgenic expression of green fluorescent protein (GFP) [12] . These results suggest that the sensitivity to RNAi in C. elegans is dependent on neuron subtype and specific neuronal properties.
Materials and methods

Worm strains
Worms were grown on nematode growth medium (NGM) agar plates at 201C, unless otherwise indicated. C. elegans transgenic strains were derived from N2 [13] . Strains used to test the level of interference with GFP were AZ217 (P myo-2 ::GFP) expressing GFP in the pharynx muscle (nonneuronal control strain) [14] , SA1002 (P aex-3 ::GFP) expressing GFP in all neurons [15] , EG1285 (P unc-47 ::GFP) strain expressing GFP in GABAergic neurons [16] , SA1003 (P dat-1 ::GFP) expressing GFP in dopaminergic neurons [17] , SA1001 (P acr-2 ::GFP) expressing GFP in cholinergic neurons [18] , SK4005 (P mec-4 ::GFP) expressing GFP in touch neurons [19] and DA1240 (P eat-4 ::GFP) expressing GFP in glutamatergic neurons [20] . Strains AZ217, EG1285, SK4005 and DA1240 were provided by the Caenorhabditis Genetics Center (Minneapolis, Minnesota, USA) and the remaining GFP strains were made by transgenic injection followed by integration using X-ray irradiation. The GFP-expressing transgenic lines were also crossed with the homozygous rrf-3 deletion mutant strain NL2099 (pk 1426), which has a B3 kbp deletion leading to dysfunction of RRF-3 protein [10] . The homozygous crossed deletion allele was confirmed first by analyzing the mutant phenotype (temperaturesensitive reproduction repression at 251C) and afterwards additionally by performing polymerase chain reaction (PCR) using rrf-3 specific primers (data not shown). Primer sequences used were as follows: forward, 5 0 -CGAGTTCG-CATCAAGTTTCA and reverse, 5 0 AGCTGCCAAATCGA-CAAAAC. To isolate DNA, worms were lysed in lysis buffer (10 mM Tris, 50 mM KCl, 2.5 mM MgCl 2 , 0.45% Tween, 0.01% gelatin, 0.45% Nonidet 40 and 2 mg/ml proteinase K). The PCR mixture included 3 ml worm lysate for 50 ml of final volume, 10 Â Taq pol buffer, 1.9 mM MgCl 2, 0.25 mM deoxynucleotide triphosphate, 20 ng forward primer, 20 ng reverse primer and 2.5 U Taq polymerase (New England Biolabs, Ipswich, Massachusetts, USA). The cycles used were as follows: step 1, 941C 1 min 15 s; step 2, 561C 2 min; step 3, 721C 5 min; step 4, 941C 45 s; step 5, 561C 45; step 6, 721C 1 min 30 s and step 7, 721C 15 min. Steps 4-6 were repeated 30 times.
RNA interference treatments dsRNA was administered to worms using injecting, feeding and soaking protocols. Injections of dsRNA were performed as previously described [5] . pRN200 [17] was used as a template for PCR to amplify the GFP fragment. The gfpspecific primers were as follows: forward, 5 0 -CCCTAATA-CGACTCACTATAGGGAATGAGTAAAGGAGAAGAACT and reverse, 5 0 -CCCTAATACGACTCACTATAGGGATTTG-TATAGTTCATCCATGC. The PCR mixture included 10 Â Taq buffer, 1.9 mM MgCl 2 , 0.3 mM deoxynucleotide triphosphate mix, 20 ng forward primer, 20 ng reverse primer, 35 ng pRN200 template and 2.5 U Taq polymerase (New England Biolabs). The following cycles were used: step 1, 951C 2 min; step 2, 651C 2 min; step 3, 721C 5 min; step 4, 951C 30 s; step 5, 651C 1 min 30 s and step 6, 721C 1 min 30 s. Steps 4-6 were repeated 24 times. dsRNA was synthesized in vitro using T7 RNA polymerase (Invitrogen, Carlsbad, California, USA) and GFP fragment as a template with 5 Â T7 buffer, 0.4 mM nucleotide triphosphate, 5 mM dithiothreitol, 0.1 mg linearized GFP template and 50 U T7 polymerase. The mixture was incubated at 371C for 30 min, followed by phenol-chloroform extraction and isopropanol precipitation. L4 worms were injected with dsRNA (0.5 mg/ml) into the digestive tract and transferred onto fresh plates after 4 or 24 h. Phenotypes of the progeny were observed after 72 h at the L4 stage.
Worms were fed using transformed bacteria [21] . The bacteria strain HT 115 (DE 3) was transformed with the L4440 vector containing a fragment complementary to the gfp gene under the inducible double T7-promoter. A single colony of plasmid-containing bacteria in 2 ml Luria broth (LB) was grown overnight at 371C. Antibiotics were added to a final concentration of 12 mg/ml tetracycline and 50 mg/ml carbenicillin or 50 mg/ml ampicillin. After overnight incubation, isopropyl-b-D thiogalactopyranoside (IPTG) was added to LB at a final concentration of 0.8 mM and the culture was incubated with shaking for 4 h at 371C. After incubation, the bacterial medium was concentrated by centrifuge and an additional 50 mg/ml carbenicillin or ampicillin, 10 mg/ml tetracycline and IPTG were added. The bacteria were applied to NGM agar plates containing equal amounts of tetracycline, ampicillin or carbenicillin, and IPTG as described in the above LB solution. Three young worms (L2-L3) were added per plate, and the parent worms were removed after 48 h. F1 progeny were analyzed after 72 h. Worms were soaked as described previously [22] using 1.0 mg/ml dsRNA in 5 mM Tris-HCl solution placed on the tip of a PCR tube. Six to 10 young worms (L3) were transferred from NGM/agar/OP50 bacteria-containing plates to dsRNA solution, and a drop of mineral oil was added to prevent desiccation. Worms were incubated for 24 h at 201C and transferred to regular NGM/agar/OP50 bacteria-containing plates to recover. F1 progeny were analyzed after 72 h.
Analysis of phenotypes
RNAi was assayed using both GFP-transgenic wild-type (rrf-3 + / + ) and strains crossed with mutated rrf-3 (pk 1426) (rrf-3 À/À). F1 progeny were analyzed at the L4 stage using a Nikon BH 10104 AF ÀUV microscope (Nikon Corp., Tokyo, Japan). A neuron was scored as RNAi-sensitive if GFP was significantly decreased under the fluorescent microscope. When RNAi-sensitive, the GFP-marked neurons were either barely visible or not visible at all (see Fig. 1 for examples). A strain was scored as sensitive if one or more of its GFP visible neurons were RNAi-sensitive. Micrographs were taken using an Olympus AX 70 ÀUV microscope (Tokyo, Japan) with a magnification of 100 Â (neuronal GFP strains) or 200 Â (pharyngeal muscle GFP strain, glutamatergic GFP strain) with a 7 s exposure time (10 s with glutamatergic GFP strain to enhance weak GFP expression).
Results
RNAi in different C. elegans neurons were evaluated using a GFP transgene as a target sequence in worm strains with wild-type or mutated rrf-3 genetic backgrounds. GFP was expressed under pharyngeal muscle, pan-neuronal, GABAergic, dopaminergic, cholinergic, glutamatergic or touch neuron-specific promoters, and RNAi phenotypes were assayed by administration of dsRNA followed by scoring the GFP expression. A non-neuronal control strain expressing GFP in pharynx muscle (Mus) exhibited sensitivity to the RNAi targeted to the GFP transgene (Fig. 1a) . RNAi was effective in some but not all neurons in the worms expressing GFP pan-neuronally: GFP expression could still be seen in head and ventral cord neurons after dsRNA treatment. Dopaminergic and GABAergic strains were resistant to RNAi (Fig. 1a and b, Table 1 ). After GABAergic and dopaminergic neuron GFP expressing strains were crossed to rrf-3 mutants, a subset of GABAergic neurons (VD6, VD7, VD9) and dopaminergic neurons (PDE) became sensitive. All cholinergic and touch neurons were sensitive to RNAi (Fig. 1b, Table 1 ). Additionally, glutamatergic neurons exhibited sensitivity to RNAi (Fig. 1c, Table 1 ).
The rrf-3 mutation dramatically increases RNAi sensitivity in GABAergic and dopaminergic neurons (Table 1) , as these cells are resistant in a wild-type background. Cholinergic, glutamatergic and touch neurons also displayed increased sensitivity.
Discussion
Highly differentiated neuronal cells are shown to resist RNAi [6] [7] [8] when compared with non-neuronal cell types. 
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Thus, we were interested in testing the level and cell-type specificity of C. elegans neurons to RNAi. We found significant differences in sensitivity to interference with GFP: GABAergic and dopaminergic neurons showed more resistance while cholinergic, glutamatergic and touch neurons were less resistant. Neuron location does not appear to play an essential role in sensitivity to RNAi as neurons located in the head, along the ventral nerve cord and in posterior regions were sensitive. Moreover, GABAergic and cholinergic neurons were differentially sensitive even though the majority of both types of neurons reside along the ventral nerve cord. GABAergic neurons, as marked by unc-47::GFP, are AVL, DD, DVB, RIS, RME and VD [16] , while cholinergic neurons are ALN, AS, DA and DB motor neurons [18] . As there is no apparent overlap between GABAergic and cholinergic neurons, the differences in their RNAi sensitivity is most likely a property of the particular cell. An unexpected finding was that among dopaminergic neurons: the PDE neurons were sensitive to RNAi but the CEP and ADE were not. These results suggest that cell-specific properties likely determine the sensitivity to RNAi, rather than the neurotransmitter used. The mode of administration of RNAi did not appear to play an essential role in rrf-3 À/À genetic backgrounds as injection, feeding and soaking gave equivalent results. Modest differences were observed in touch and cholinergic neurons in rrf-3 + / + backgrounds. The rrf-3 mutation increased susceptibility to representative neurons from all the types tested; however, subsets of neurons appeared resistant (e.g. CEP and ADE). Additional factors necessary for RNAi may be absent from these cells. Alternatively, the presence of an RNAi inhibitor may block one or more RNAi processes in these cells. Brockie and co-workers [23] have suggested that potential glutamatergic neurons are ASH, AUA, FLP, PVD and PLM based on the expression of eat-4, a putative sodiumphosphate cotransporter, and their synapses with glutamate receptors. We assayed eat-4::GFP expressing worms and found that their GFP neurons were highly sensitive to RNAi (Fig. 1c) . We also assayed mec-4::GFP that is expressed in touch neurons including putatively glutamatergic PLM. This neuron was also sensitive.
Earlier reports have suggested that RNAi is under negative regulation by RRF-3 and that it may compete with RRF-1 for components or intermediates of the RNAi pathway [11] . Ongoing studies have placed expression of rrf-3 in intestinal, excretory cell, ventral nerve cord and head neurons, cells in which there appears to be resistance; this would be consistent with the hypothesis [24] . Thus, selective sensitivity could be determined by location of rrf-3 expression. A second gene, eri-1, was recently reported to also increase sensitivity to RNAi in C. elegans neurons when mutated [25] . This gene contains conserved domains indicating it to be a member of DEDDh nucleases that have been shown to be involved in processing and end degradation of mRNAs and tRNAs. Results similar to those presented here were reported with eri-1: GABAergic neurons as measured by unc-47::GFP overexpression that were resistant to RNAi in a wild-type background, but were sensitive in a mutated eri-1 background. The eri-1 gene is expressed in a subset of head and tail neurons. Thus, rrf-3 may prevent dsRNA amplification, while eri-1 may degrade dsRNAs in cells in which it is expressed, and thus provide resistance to RNAi.
Conclusion
Neurons display selective sensitivity to RNAi that is likely the result of cell-specific properties that includes, but is not limited to, the neurotransmitter used. The sensitivity can be altered by rrf-3 and is largely independent of the route of dsRNA administration. Transgenes are indicated along with the neuronal subtypes that the genes mark. Strains were scored sensitive if any GFP-positive neurons displayed signi¢-cantly reduced £uorescence. Results shown are number of sensitive strains out of 30 observations. The route of double-stranded RNA administration is indicated.GFP, green £uorescent protein.
